In the last 30 years, obesity has rapidly increased and obesity-related comorbidities have
surged. Once considered to be a problem only in developed nations, obesity has become a …

Obesity is a chronic disease with a continuously rising prevalence that currently affects more
than half a billion people worldwide. Energy balance and appetite are highly regulated via …

Abstract Purpose of Review This review provides an overview of the current state of drug
therapy for obesity, with a focus on four new drug therapies—lorcaserin, phentermine …

Objective: To synthesize the evidence from systematic reviews of clinical trials investigating
the effectiveness of pharmacological therapies approved by the Australian Therapeutic …

Recently, the recognition of obesity as a complex disease that requires chronic management
has become more widespread. There has also been a movement away from a focus on …

Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

Abstract Purpose of Review As a chronic and relapsing disease, obesity impairs metabolism
and causes cardiovascular diseases. Although behavioral modification is important for the …

Obesity is a growing epidemic and a major contributor to the global burden of disease.
Obesity strains the healthcare systems and has profound economic and psychosocial …

Background: The increase in global obesity rates over the past three decades has been
remarkable, a true epidemic, both in developed and in developing countries. The …

Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …